Found 266 matching trials
Bioequivalence Study to Compare Empagliflozin + Linagliptin 25 mg/5 mg Film-coated Tablets Versus Glyxambi 25 mg/ 5 mg Film-coated Tablets
PHASE1An open label, balanced, randomized, single dose, two treatment, two sequen...
Location
Veeda Clinical Research Ltd.
Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
PHASE2Sickle cell anemia (SCA) is an inherited red blood disorder. The kidneys ar...
Location
University of Illinois Chicago, Sickle Cell Center
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)
PHASE3Comparison of 2 doses of empagliflozin vs placebo in patients already using...
Location
AMCR Institute, Inc.
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
PHASE4BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Location
Unit of Endocrinology and Metabolic Diseases
Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate Hypertension
PHASE2Primary Objective:
To compare the metabolic and gastrointestinal pharmacod...
Location
Investigational Site Number 2760001
Vitamin D, K2 Plus Empagliflozin Combination in Type Two Diabetes Mellitus
PHASE3The main purpose of the VETA trial is to verify the potential beneficial ef...
Location
University of Health Sciences
Empagliflozin Versus Non-SGLT2 Oral Drugs for Blood Pressure in Type 2 Diabetes
PHASE4This randomized controlled trial studied whether empagliflozin lowers blood...
Location
Shahida Islam Medical College, Lodhran
Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients?
NAOur trial goal is to determine the efficacy and safety of sitagliptin in co...
Location
University of Sadat City
Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes
PHASE4This exploratory study will assess the efficacy of combined pioglitazone an...
Location
Seoul National University Bundang Hospital
Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs
NAThis clinical study aims to improve the diagnosis and treatment of cardiova...
Status
Active Not Recruiting
Location
PI "National Laboratory Astana", Nazarbayev University